Therapeutic Functions of Favipiravir

Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated.


Favipiravir is an antiviral molecule that is being developed for the treatment of influenza virus infections but that exerts also activity against a number of unrelated RNA viruses, including bunyaviruses, arenaviruses and flaviviruses. T-705 is converted to its active form T-705 ribofuranosyl 5’-tri-phosphate by cellular enzymes.


This is collected by BOC Sciences. 

This article duplicated from: https://www.bocsci.com/t-705-cas

No corresponding comment


X
You’ve spoken and we’ve listened! We are excited to announce that the same great knowledge platform that you have come use and love over the years will be going through a rebrand and an upgrade. We believe that all good things don’t come to an end, but only evolve to be better. WikiOmni will now officially be called Knowpia. Please make sure your access is now directed to KNOWPIA.COM from all of your devices. In an effort to enhance the overall user experience, over the course of the next few months you will see a new and improved design layout with value-added features and advancements in functionality. Through extensive research & development, we know you will be happy with the new direction that we are taking to continue our vision to assemble the world’s largest platform of knowledge contributors. We thank you for taking this incredible journey with us!